ACADIA Pharmaceuticals (ACAD)
(Delayed Data from NSDQ)
$15.20 USD
-0.34 (-2.19%)
Updated May 24, 2024 04:00 PM ET
After-Market: $15.21 +0.01 (0.07%) 4:18 PM ET
3-Hold of 5 3
C Value A Growth F Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/07/2024
Time: -- |
6/2024 | $0.16 | -9.91% |
Earnings Summary
For their last quarter, ACADIA Pharmaceuticals (ACAD) reported earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.04 per share. This reflects a positive earnings surprise of 150.00%. Look out for ACAD's next earnings release expected on August 07, 2024. For the next earning release, we expect the company to report earnings of $0.16 per share, reflecting a year-over-year increase of 1500%.
Earnings History
Price & Consensus
Zacks News for ACAD
Acadia Pharmaceuticals (ACAD) Tops Q1 Earnings Estimates
ACAD: What are Zacks experts saying now?
Zacks Private Portfolio Services